Multiple endocrine neoplasia type 2

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 24, Issue 3, 2010, Pages 371-387

  Wohllk, Nelson ^a   Schweizer, Heiko ^b   Erlic, Zoran ^b,c   Schmid, Kurt Werner ^d   Walz, Martin K ^e   Raue, Friedhelm ^f   Neumann, Hartmut P H ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e KLINIKEN ESSEN MITTE   (Germany)

^f Endocrine Practice   (Germany)

Author keywords

C cell hyperplasia; hyperparathyroidism; medullary thyroid carcinoma; multiple endocrine neoplasia type 2; pheochromocytoma; RET proto oncogene

Indexed keywords

CALCIMIMETIC AGENT; CINACALCET; DNA; IMATINIB; MOTESANIB; PROTEIN RET; PROTEIN TYROSINE KINASE INHIBITOR; SOMATOSTATIN; SORAFENIB; SUNITINIB; VANDETANIB; XL 184;

ADRENALECTOMY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; COUNSELING; ENDOSCOPIC ADRENAL SPARING SURGERY; FOLLOW UP; GENE MAPPING; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; MEDICAL LITERATURE; METASTASIS; NEUROFIBROMATOSIS; OUTCOME ASSESSMENT; PHEOCHROMOCYTOMA; PRIMARY HYPERPARATHYROIDISM; PROGNOSIS; REGISTER; REVIEW; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADRENAL GLAND NEOPLASMS; ADULT; CARCINOMA, MEDULLARY; CHILD; GERM-LINE MUTATION; HUMANS; HYPERPARATHYROIDISM; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PHEOCHROMOCYTOMA; PROTO-ONCOGENE PROTEINS C-RET; THYROID NEOPLASMS;

EID: 77956581017     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2010.02.001     Document Type: Review

References (98)

1. J.R. Howe, J.A. Norton, and S.A. Wells Jr. Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up Surgery 114 1993 1070 1077
2. M. Brauckhoff, A. Machens, and S. Hess Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: an exploratory analysis Surgery 144 2008 1044 1050 discussion 1050-3
3. R.T. Kloos, C. Eng, and D.B. Evans Medullary thyroid cancer: management guidelines of the American Thyroid Association Thyroid 19 2009 565 612
4. R.F. Gagel, M.L. Levy, and D.T. Donovan Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis Annals of Internal Medicine 111 1989 802 806
5. M. Verdy, A.M. Weber, and C.C. Roy Hirschsprung's disease in a family with multiple endocrine neoplasia type 2 Journal of Pediatric Gastroenterology and Nutrition 1 1982 603 607
6. R.A. DeLellis, R.V. Lloyd, and P.U. Heitz WHO classification of tumours, pathology and genetics of tumours of endocrine organs 2004 IARC Press Lyon, France
7. Cancer facts and figures 2009 2009 American Cancer Society
8. National Cancer Institute Surveillance epidemiology and end results: SEER stat fact sheets - update May 29, 2009 2006 National Cancer Institute
9. S.A. Hundahl, I.D. Fleming, and A.M. Fremgen A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the US, 1985-1995 [see comments] Cancer 83 1998 2638 2648
10. F. Raue German medullary thyroid carcinoma/multiple endocrine neoplasia registry. German MTC/MEN Study Group. Medullary Thyroid Carcinoma/Multiple Endocrine Neoplasia Type 2 Langenbeck's Archives of Surgery 383 1998 334 336
11. R. Elisei, V. Bottici, and F. Luchetti Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders The Journal of Clinical Endocrinology and Metabolism 89 2004 163 168
12. C. Eng, L.M. Mulligan, and D.P. Smith Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma Clinical Endocrinology 43 1995 123 127
13. N. Wohllk, G.J. Cote, and M.M. Bugalho Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma The Journal of Clinical Endocrinology and Metabolism 81 1996 3740 3745
14. S. Roman, R. Lin, and J.A. Sosa Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases Cancer 107 2006 2134 2142
15. H.P. Neumann, A. Vortmeyer, and D. Schmidt Evidence of MEN-2 in the original description of classic pheochromocytoma The New England Journal of Medicine 357 2007 1311 1315
16. J.B. Hazard, W.A. Hawk, and G. Crile Jr. Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity The Journal of Clinical Endocrinology and Metabolism 19 1959 152 161
17. J.H. Sipple The association of pheochromocytoma with carcinoma of the thyroid gland The American Journal of Medicine 31 1961 163 166
18. A.L. Steiner, A.D. Goodman, and S.R. Powers Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2 Medicine (Baltimore) 47 1968 371 409
19. A. Wagenmann Multiple Neurome des Auges und der Zunge Bericht uber die zusammenkunft. Deutsche Ophthalmologische Gesellschaft. 282-5 1922
20. E.D. Williams, and D.J. Pollock Multiple mucosal neuromata with endocrine tumours: a syndrome allied to von Recklinghausen's disease The Journal of Pathology and Bacteriology 91 1966 71 80
21. R.J. Gorlin, and R.A. Vickers Multiple mucosal neuromas, pheochromocytoma, medullary carcinoma of the thyroid and marfanoid body build with muscle wasting: reexamination of a syndrome of neural crest malmigration Birth Defects Original Article Series 7 1971 69 72
22. J.R. Farndon, G.S. Leight, and W.G. Dilley Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity The British Journal of Surgery 73 1986 278 281
23. M.L. Brandi, R.F. Gagel, and A. Angeli Guidelines for diagnosis and therapy of MEN type 1 and type 2 The Journal of Clinical Endocrinology and Metabolism 86 2001 5658 5671
24. B.A. Ponder Multiple endocrine neoplasia type 2 B. Vogelstein, K.W. Kinzler, The genetic basis of human cancer 2002 McGraw-Hill New York, NY 501 513
25. N.E. Simpson, K.K. Kidd, and P.J. Goodfellow Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage Nature 328 1987 528 530
26. C.G. Mathew, K.S. Chin, and D.F. Easton A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10 Nature 328 1987 527 528
27. R.A. Norum, R.G. Lafreniere, and L.W. O'Neal Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A Genomics 8 1990 313 317
28. T.C. Lairmore, J.R. Howe, and J.A. Korte Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A Genomics 9 1991 181 192
29. L.M. Mulligan, J.B. Kwok, and C.S. Healey Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A Nature 363 1993 458 460
30. H. Donis-Keller, S. Dou, and D. Chi Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC Human Molecular Genetics 2 1993 851 856
31. R.M. Hofstra, R.M. Landsvater, and I. Ceccherini A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma Nature 367 1994 375 376
32. M. Takahashi, J. Ritz, and G.M. Cooper Activation of a novel human transforming gene, ret, by DNA rearrangement Cell 42 1985 581 588
33. M. Santoro, R.M. Melillo, and F. Carlomagno Minireview: RET: normal and abnormal functions Endocrinology 145 2004 5448 5451
34. E. de Graaff, S. Srinivas, and C. Kilkenny Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis Genes & Development 15 2001 2433 2444
35. M.S. Airaksinen, and M. Saarma The GDNF family: signalling, biological functions and therapeutic value Nature Reviews. Neuroscience 3 2002 383 394
36. M. Ichihara, Y. Murakumo, and M. Takahashi RET and neuroendocrine tumors Cancer Letters 204 2004 197 211
37. Y. Hayashi, T. Iwashita, and H. Murakamai Activation of BMK1 via tyrosine 1062 in RET by GDNF and MEN2A mutation Biochemical and Biophysical Research Communications 281 2001 682 689
38. M. Santoro, F. Carlomagno, and A. Romano Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B Science 267 1995 381 383
39. M. Takahashi, T. Iwashita, and M. Santoro Co-segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss-of-function? Human Mutation 13 1999 331 336
40. R. Elisei, C. Romei, and B. Cosci RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center The Journal of Clinical Endocrinology and Metabolism 92 2007 4725 4729
41. Multiple endocrine neoplasia type 2 (MEN2) 2010 ARUP Online Scientific Resource
42. Z. Erlic, M.M. Hoffmann, and M. Sullivan Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome The Journal of Clinical Endocrinology and Metabolism 95 2010 308 313
43. R.L. Margraf, D.K. Crockett, and P.M. Krautscheid Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations Human Mutation 30 2009 548 556
44. J.R. Gill, M. Reyes-Mugica, and S. Iyengar Early presentation of metastatic medullary carcinoma in multiple endocrine neoplasia, type IIA: implications for therapy The Journal of Pediatrics 129 1996 459 464
45. S. Leboulleux, J.P. Travagli, and B. Caillou Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course Cancer 94 2002 44 50
46. A. Machens, H.J. Holzhausen, and P.N. Thanh Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations Surgery 134 2003 425 431
47. M.K. Punales, H. Graf, and J.L. Gross RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome The Journal of Clinical Endocrinology and Metabolism 88 2003 2644 2649
48. I.N. Milos, K. Frank-Raue, and N. Wohllk Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation Endocrine-Related Cancer 15 2008 1035 1041
49. K.M. Zbuk, and C. Eng Cancer phenomics: RET and PTEN as illustrative models Nature Reviews. Cancer 7 2007 35 45
50. A.G. Pearse The cytochemistry of the thyroid C cells and their relationship to calcitonin Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character 164 1966 478 487
51. R.A. DeLellis, G. Nunnemacher, and H.J. Wolfe C-cell hyperplasia. An ultrastructural analysis Laboratory Investigation 36 1977 237 248
52. J. Rosai, M. Carcangiu, and R.A. DeLellis Tumors of the thyroid gland Atlas of tumor pathology vol. 5 1992 AFIP Washington DC
53. R.V. Lloyd, J.C. Sisson, and P.J. Marangos Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma Cancer 51 1983 2234 2239
54. H.J. Wolfe, E.F. Voelkel, and A.H. Tashjian Jr. Distribution of calcitonin-containing cells in the normal adult human thyroid gland: a correlation of morphology with peptide content The Journal of Clinical Endocrinology and Metabolism 38 1974 688 694
55. H.R. Harach Histogenesis of thyroid C-cell carcinoma Current Topics in Pathology 91 1997 15 20
56. B.A. Burke, D. Johnson, and E.F. Gilbert Thyrocalcitonin-containing cells in the Di George anomaly Human Pathology 18 1987 355 360
57. W.C. Gibson, T.C. Peng, and B.P. Croker C-cell nodules in adult human thyroid. A common autopsy finding American Journal of Clinical Pathology 75 1981 347 350
58. S. Guyetant, M.C. Rousselet, and M. Durigon Sex-related C cell hyperplasia in the normal human thyroid: a quantitative autopsy study The Journal of Clinical Endocrinology and Metabolism 82 1997 42 47
59. K. Kaserer, C. Scheuba, and N. Neuhold Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients The American Journal of Surgical Pathology 25 2001 1245 1251
60. G. Bussolati, F.W. Rost, and A.G. Pearse Fluorescence metachromasia in polypeptide hormone-producing cells of the APUD series, and its significance in relation to the structure of the precursor protein The Histochemical Journal 1 1969 517 530
61. E.D. Williams, B.J. Ponder, and R.K. Craig Immunohistochemical study of calcitonin gene-related peptide in human medullary carcinoma and C cell hyperplasia Clinical Endocrinology 27 1987 107 114
62. K.W. Schmid, R. Kirchmair, and D. Ladurner Immunohistochemical comparison of chromogranins A and B and secretogranin II with calcitonin and calcitonin gene-related peptide expression in normal, hyperplastic and neoplastic C-cells of the human thyroid Histopathology 21 1992 225 232
63. R. Buffa, G. Rindi, and F. Sessa Synaptophysin immunoreactivity and small clear vesicles in neuroendocrine cells and related tumours Molecular and Cellular Probes 1 1987 367 381
64. T. Kodama, M. Fujino, and Y. Endo Identification of carcinoembryonic antigen in the C-cell of the normal thyroid Cancer 45 1980 98 101
65. H.J. Wolfe, K.E. Melvin, and S.J. Cervi-Skinner C-cell hyperplasia preceding medullary thyroid carcinoma The New England Journal of Medicine 289 1973 437 441
66. V.A. LiVolsi, C.R. Feind, and P. LoGerfo Demonstration by immunoperoxidase staining of hyperplasia of parafollicular cells in the thyroid gland in hyperparathyroidism The Journal of Clinical Endocrinology and Metabolism 37 1973 550 559
67. H.J. Wolfe, and R.A. Delellis Familial medullary thyroid carcinoma and C cell hyperplasia Clinics in Endocrinology and Metabolism 10 1981 351 365
68. A. Machens, P. Niccoli-Sire, and J. Hoegel Early malignant progression of hereditary medullary thyroid cancer The New England Journal of Medicine 349 2003 1517 1525
69. A. Perry, K. Molberg, and J. Albores-Saavedra Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities Cancer 77 1996 750 756
70. E. Saggiorato, I. Rapa, and F. Garino Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia The Journal of Molecular Diagnostics 9 2007 214 219
71. G. Papi, G. Rosi, and S.M. Corsello Nodular disease and parafollicular C-cell distribution: results from a prospective and retrospective clinico-pathological study on the thyroid isthmus European Journal of Endocrinology 162 2010 137 143
72. K.E. Melvin, and A.H. Tashjian Jr. The syndrome of excessive thyrocalcitonin produced by medullary carcinoma of the thyroid Proceedings of the National Academy of Sciences of the United States of America 59 1968 1216 1222
73. K.E. Melvin, H.H. Miller, and A.H. Tashjian Jr. Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay The New England Journal of Medicine 285 1971 1115 1120
74. B. Muller, J.C. White, and E.S. Nylen Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis The Journal of Clinical Endocrinology and Metabolism 86 2001 396 404
75. E.S. Nylen, K.T. Whang, and R.H. Snider Jr. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis Critical Care Medicine 26 1998 1001 1006
76. A. Machens, S. Hauptmann, and H. Dralle Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer World Journal of Surgery 31 2007 1960 1965
77. C.F. Russell, J.A. Van Heerden, and G.W. Sizemore The surgical management of medullary thyroid carcinoma Annals of Surgery 197 1983 42 48
78. H. Dralle, I. Damm, and G.F. Scheumann Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma Surgery Today 24 1994 112 121
79. H. Dralle, A. Machens, and K. Lorenz Hereditary thyroid cancer Chirurg 79 2008 1017 1028
80. M.A. Skinner, J.A. Moley, and W.G. Dilley Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A The New England Journal of Medicine 353 2005 1105 1113
81. American-Thyroid-Association Calcitonin and carcinoembryonic antigen (CEA) doubling time calculator 2010 http://www.thyroid.org/professionals/ calculators/CDTC.php
82. A. Laure Giraudet, A. Al Ghulzan, and A. Auperin Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times European Journal of Endocrinology 158 2008 239 246
83. D.W. Ball Medullary thyroid cancer: monitoring and therapy Endocrinology and Metabolism Clinics of North America 36 2007 823 837 viii
84. S.I. Sherman Advances in chemotherapy of differentiated epithelial and medullary thyroid cancers The Journal of Clinical Endocrinology and Metabolism 94 2009 1493 1499
85. V. Gupta-Abramson, A.B. Troxel, and A. Nellore Phase II trial of sorafenib in advanced thyroid cancer Journal of Clinical Oncology 26 2008 4714 4719
86. K. Frank-Raue, M. Fabel, and S. Delorme Efficacy of imatinib mesylate in advanced medullary thyroid carcinoma European Journal of Endocrinology 157 2007 215 220
87. H.P. Neumann Chapter 337: Pheochromocytoma A.S. Fauci, Harrison's principles of internal medicine 2008 McGraw Hill New York
88. H.P. Neumann, B. Bausch, and S.R. McWhinney Germ-line mutations in nonsyndromic pheochromocytoma The New England Journal of Medicine 346 2002 1459 1466
89. B. Bausch, W. Borozdin, and H.P. Neumann Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma The New England Journal of Medicine 354 2006 2729 2731
90. C.C. Boedeker, Z. Erlic, and S. Richard Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2 The Journal of Clinical Endocrinology and Metabolism 94 2009 1938 1944
91. M.K. Walz, and P.F. Alesina Single access retroperitoneoscopic adrenalectomy (SARA)-one step beyond in endocrine surgery Langenbeck's Archives of Surgery 394 2009 447 450
92. M.K. Walz, P.F. Alesina, and F.A. Wenger Posterior retroperitoneoscopic adrenalectomy-results of 560 procedures in 520 patients Surgery 140 2006 943 948 discussion 948-50
93. J.L. Kraimps, A. Denizot, and B. Carnaille Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs a Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons World Journal of Surgery 20 1996 808 812 discussion 812-3
94. E. Modigliani, R. Cohen, and J.M. Campos Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'etude des tumeurs a calcitonine Clinical Endocrinology 48 1998 265 273
95. F. Raue, J.L. Kraimps, and H. Dralle Primary hyperparathyroidism in multiple endocrine neoplasia type 2A Journal of Internal Medicine 238 1995 369 373
96. L. Yip, G.J. Cote, and S.E. Shapiro Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship Archives of Surgery 138 2003 409 416 discussion 416
97. I. Schuffenecker, M. Virally-Monod, and R. Brohet Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs a Calcitonine The Journal of Clinical Endocrinology and Metabolism 83 1998 487 491
98. L.H. Sobin, M.K. Gospodarowicz, and C. Wittekind TNM classification of malignant tumours 2009 Wiley-Blackwell pp. 58-62